Felbamate
Who holds supplier records for Felbamate? 7 organisations hold a current record for Felbamate: an active US FDA Type II Drug Master File. A further 5 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (4), Italy (1), Switzerland (1) and Israel (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Felbamate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/felbamate
Reading the evidence
- 7 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 5 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (7)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Felbamate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 22958, 39207 · latest filing Dec 2023
- Emcure Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 29408 · latest filing Jun 2015
- PROCOS SPAItaly Company GMP cert on recordActive DMF 21247 · latest filing Jan 2008
- RAKS PHARMA PVT LTDIndiaActive DMF 31181 · latest filing Dec 2016
- SIEGFRIED EVIONNAZ SASwitzerland Company GMP cert on recordActive DMF 8304 · latest filing Nov 1989
- SOLARA ACTIVE PHARMA SCIENCES LTDIndia Company GMP cert on recordActive DMF 22810 · latest filing Jun 2009
- Taro Pharmaceutical Industries Ltd.Israel Company GMP cert on recordActive DMF 27331 · latest filing Nov 2013
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (5)
Organisations whose Type II DMFs for Felbamate are no longer active. These show a past filing, not current supply.
Show all 5 historical records
- India · Inactive DMF 28661 · filed Nov 2015
- India · Inactive DMF 22201 · filed Nov 2008
- United States · Inactive DMF 20438 · filed Apr 2007
- GANES CHEMICALS INC PENNSVILLE DIVInactive DMF 9352 · filed Sept 1991
- France · Inactive DMF 9268 · filed Jul 1991
Overview
Felbamate is an anticonvulsant medication primarily used in the treatment of epilepsy. It is administered to patients who have severe epileptic seizures when other treatments have not been successful.
Chemical identity
- IUPAC name
- (3-carbamoyloxy-2-phenylpropyl) carbamate
- Canonical SMILES
- C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N
- InChIKey
- WKGXYQFOCVYPAC-UHFFFAOYSA-N
- Synonyms
- Felbatol API, 2-phenyl-1,3-propanediol 1,3-dicarbamate, add-03055, carbamic acid 2-phenyltrimethylene ester, felbatol, nsc-759866, taloxa, w-554
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Anti-epileptic Agent
- Physiologic effect
- Decreased Central Nervous System Disorganized Electrical Activity
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Felbamate?
7 organisations hold an active US FDA Type II Drug Master File or a CEP for Felbamate: MATRIX PHARMACORP PRIVATE LTD (India), Emcure Pharmaceuticals Limited (India), PROCOS SPA (Italy), RAKS PHARMA PVT LTD (India), SIEGFRIED EVIONNAZ SA (Switzerland), SOLARA ACTIVE PHARMA SCIENCES LTD (India) and Taro Pharmaceutical Industries Ltd. (Israel). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Felbamate Drug Master Files are active?
MATRIX PHARMACORP PRIVATE LTD (DMF 22958, 39207), Emcure Pharmaceuticals Limited (DMF 29408), PROCOS SPA (DMF 21247), RAKS PHARMA PVT LTD (DMF 31181), SIEGFRIED EVIONNAZ SA (DMF 8304), SOLARA ACTIVE PHARMA SCIENCES LTD (DMF 22810) and Taro Pharmaceutical Industries Ltd. (DMF 27331). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Felbamate records mean?
5 organisations have only inactive Type II DMFs for Felbamate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Felbamate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Felbamate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.